Browsing: Clinical

47-3 US-Guided IV.png
Placement of an ultrasound-guided peripheral intravenous line (USPIV) is a common and relatively safe procedure. Don't fall into bad habits that lead to unsuccessful placement. Review the most common
47-3 Nerve Agents - Symptoms.png
Nerve agents are one of the most terrifying weapons of war. With many direct pathophysiologic effects, the psychological terror they instill is often the intent of their use. Emergency medicine provid
47-3 Strongyloides_LifeCycle_lg.jpg
Strongyloidiasis is an infection of the parasitic nematode, Strongyloides stercoralis. This condition is well-known in global health as a concern among immigrants and refugees, but it is also present
47-3 Until Help Arrives.jpg
For a long time, prehospital emergency medicine education was limited to those training for jobs in the field. Only in the last several decades have mass education initiatives emphasized emergency med
47-3 Informatics.jpg
Are you interested in a career in clinical informatics? Find out how to get involved while this emerging niche is still in the grandfathering phase.
47-3 Atypical HUS - Anchor.jpg
A young woman presents with a 3-week history of fatigue, nausea, vomiting, heavy bleeding, and lightheadedness. Within hours she is intubated in the ICU. Follow the case management to understand an at
47-3 Tumor Neglect.png
Challenges with health care literacy, lack of insurance, and simple human fear can sometimes lead patients to delay seeking help - or even deny a problem exists. Tread lightly to offer the best care i
47-3 Brown Recluse - anchor.png
Although spider bite is a common complaint in the ED, systemic loxoscelism is a rare and deadly consequence of undiagnosed brown recluse bites. Use the NOT RECLUSE mnemonic to keep from missing it.
Riot Agent Injury.jpg
As protests have turned violent in response to the death of George Floyd, riot control agents have gained national attention. Exposures are now commonplace, and it's important for emergency physicians
cca-remdesivir.jpg
The Adaptive COVID-19 Treatment Trial (ACTT), while controversial, is the first major trial to suggest benefit from remdesivir for hospitalized COVID-19 patients. Unfortunately, study results don't sh